Clinical Trials for Mesothelioma Patients: NGR-hTNF Study Description

Read the study description for current clinical trials being conducted to study the effects of NGR-hTNF for patients who have been diagnosed with mesothelioma. Please note: this information is provided by Weitz & Luxenberg for informational purposes only. At this time, the study is currently being conducted only in Milan, Italy.

Primary Outcome Measures:
Antitumor activity defined as progression free survival (PFS)

Secondary Outcome Measures:
Tumor Growth Control Rate (TGCR) according to RECIST criteria
Overall survival (OS)

Detailed Description:
This is a phase II, open-label, non-randomized study that will be conducted in patients affected by advanced or metastatic malignant pleural mesothelioma previously treated with no more than one systemic therapeutic regimen , that will be conducted using Simon’s two-stage design method.

Other helpful links:

Asbestos Asbestos
Asbestos and lung cancer Asbestos and lung cancer
Mesothelioma attorney Mesothelioma attorney
Mesothelioma Lawyer Mesothelioma lawyer
Asbestos attorney Asbestos attorney